Functions of laser light, laser-absorbing dye, and immunoadjuvants in photodynamic immunotherapy

Wei R. Chen, Hong Liu, K. Bartels, R. Nordquist
{"title":"Functions of laser light, laser-absorbing dye, and immunoadjuvants in photodynamic immunotherapy","authors":"Wei R. Chen, Hong Liu, K. Bartels, R. Nordquist","doi":"10.1117/12.403939","DOIUrl":null,"url":null,"abstract":"Photo Dynamic Immuno Therapy (PDIT) is a novel approach for treatment of metastatic tumors. It involves an intratumor administration of a laser-absorbing dye and an immunoadjuvant, followed by a non-invasive laser irradiation. Previous studies using a novel immunoadjuvant, glycated chitosan, showed the effect of the treatment on a metastatic breast tumor in rats, including the eradication of treated primary tumors, regression of untreated metastases, and the evidence of immune responses induced by the treatment. To further understand the mechanism of PDIT, tumor-bearing rats were treated by different combinations of the three PDIT components. The rat survival rates and profiles of primary and metastatic tumors, after treatment by individual component and different combinations of components, were analyzed. All the experimental groups without using immunoadjuvant showed none or little positive effect. The use of glycated chitosan, either by itself or in combination of other components, has showed that among the concentrations of 0.5%, 1% and 2%, glycated chitosan was most effective at 1% in PDIT. Another immunoadjuvant, incomplete Freund's adjuvant, was also used and the results were compared with that of using glycated chitosan. PDIT was applied to a different tumor model- Met-Lu, a prostatic tumor with lung metastases in male rats and the preliminary results are reported.","PeriodicalId":376509,"journal":{"name":"Optics and Optoelectronic Inspection and Control","volume":"119 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2000-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Optics and Optoelectronic Inspection and Control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1117/12.403939","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Photo Dynamic Immuno Therapy (PDIT) is a novel approach for treatment of metastatic tumors. It involves an intratumor administration of a laser-absorbing dye and an immunoadjuvant, followed by a non-invasive laser irradiation. Previous studies using a novel immunoadjuvant, glycated chitosan, showed the effect of the treatment on a metastatic breast tumor in rats, including the eradication of treated primary tumors, regression of untreated metastases, and the evidence of immune responses induced by the treatment. To further understand the mechanism of PDIT, tumor-bearing rats were treated by different combinations of the three PDIT components. The rat survival rates and profiles of primary and metastatic tumors, after treatment by individual component and different combinations of components, were analyzed. All the experimental groups without using immunoadjuvant showed none or little positive effect. The use of glycated chitosan, either by itself or in combination of other components, has showed that among the concentrations of 0.5%, 1% and 2%, glycated chitosan was most effective at 1% in PDIT. Another immunoadjuvant, incomplete Freund's adjuvant, was also used and the results were compared with that of using glycated chitosan. PDIT was applied to a different tumor model- Met-Lu, a prostatic tumor with lung metastases in male rats and the preliminary results are reported.
激光、激光吸收染料和免疫佐剂在光动力免疫治疗中的作用
光动态免疫疗法(PDIT)是一种治疗转移性肿瘤的新方法。它包括肿瘤内激光吸收染料和免疫佐剂的管理,然后是非侵入性激光照射。先前使用一种新型免疫佐剂糖基化壳聚糖的研究表明,糖基化壳聚糖对大鼠转移性乳腺肿瘤的治疗效果,包括治疗过的原发肿瘤的根除,未治疗的转移灶的消退,以及治疗诱导的免疫反应的证据。为了进一步了解PDIT的作用机制,我们对荷瘤大鼠进行了PDIT三组分的不同组合治疗。分析单独成分和不同成分组合治疗后原发性和转移性肿瘤的大鼠存活率和概况。未使用免疫佐剂的试验组均无阳性或阳性效果甚微。糖化壳聚糖单独或与其他组分联合使用的结果表明,在0.5%、1%和2%的浓度下,糖化壳聚糖在1%的浓度下对PDIT最有效。另一种免疫佐剂,不完全弗氏佐剂,也被使用,并与使用糖化壳聚糖的结果进行比较。将PDIT应用于另一种肿瘤模型Met-Lu(雄性大鼠肺转移性前列腺肿瘤),并报道了初步结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书